These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7024084)
1. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine. Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084 [TBL] [Abstract][Full Text] [Related]
2. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine. Du H; Shi J; Cui D; Zhang Y Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975 [TBL] [Abstract][Full Text] [Related]
3. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748 [TBL] [Abstract][Full Text] [Related]
4. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions. Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029 [TBL] [Abstract][Full Text] [Related]
5. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. Nakagawa SH; Tager HS J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607 [TBL] [Abstract][Full Text] [Related]
6. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872 [TBL] [Abstract][Full Text] [Related]
7. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes. Cara JF; Nakagawa SH; Tager HS Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179 [TBL] [Abstract][Full Text] [Related]
8. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin. Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147 [TBL] [Abstract][Full Text] [Related]
9. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin. Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y Experientia; 1981; 37(8):811-3. PubMed ID: 7026270 [TBL] [Abstract][Full Text] [Related]
10. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin. Jørgensen AM; Olsen HB; Balschmidt P; Led JJ J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633 [TBL] [Abstract][Full Text] [Related]
11. Structural integrity of the B24 site in human insulin is important for hormone functionality. Žáková L; Kletvíková E; Veverka V; Lepsík M; Watson CJ; Turkenburg JP; Jirácek J; Brzozowski AM J Biol Chem; 2013 Apr; 288(15):10230-40. PubMed ID: 23447530 [TBL] [Abstract][Full Text] [Related]
12. Aromatic anchor at an invariant hormone-receptor interface: function of insulin residue B24 with application to protein design. Pandyarajan V; Smith BJ; Phillips NB; Whittaker L; Cox GP; Wickramasinghe N; Menting JG; Wan ZL; Whittaker J; Ismail-Beigi F; Lawrence MC; Weiss MA J Biol Chem; 2014 Dec; 289(50):34709-27. PubMed ID: 25305014 [TBL] [Abstract][Full Text] [Related]
13. An insulin with the native sequence but virtually no activity. Wollmer A; Gilge G; Brandenburg D; Gattner HG Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179 [TBL] [Abstract][Full Text] [Related]
14. Shortened insulin with enhanced in vitro potency. Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338 [TBL] [Abstract][Full Text] [Related]
15. Lilly lecture 1983. Abnormal products of the human insulin gene. Tager HS Diabetes; 1984 Jul; 33(7):693-9. PubMed ID: 6376225 [TBL] [Abstract][Full Text] [Related]
16. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Shoelson S; Fickova M; Haneda M; Nahum A; Musso G; Kaiser ET; Rubenstein AH; Tager H Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7390-4. PubMed ID: 6424111 [TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus caused by mutations in human insulin: analysis of impaired receptor binding of insulins Wakayama, Los Angeles and Chicago using pharmacoinformatics. Islam MA; Bhayye S; Adeniyi AA; Soliman ME; Pillay TS J Biomol Struct Dyn; 2017 Mar; 35(4):724-737. PubMed ID: 26950281 [TBL] [Abstract][Full Text] [Related]
18. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions. Mirmira RG; Tager HS Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer. Zoete V; Meuwly M; Karplus M J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246 [TBL] [Abstract][Full Text] [Related]
20. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant. Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]